| Application no. and date | 10720107.1 (espacenet) (Federated) (European Patent Register), 20100519 | | Patent/reg. no. and date | DK/EP 2391355, 20170118 | | Publication date | 20111207 | | Priority no. and date | US 179678 P, 20090519 | | EP pub. no. and date |
EP 2391355 20111207 | | Effective date | | | Applicant/owner | Celgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P60875DK01 | | Inventor | TUTINO, Anthony, 104 Hickson Drive
New Providence
NJ 07974, US,
KELLY, Michael T., 43 Lorettacong Drive
Lake Hopatcong
NJ 07849, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 47/10 (2017.01) , A61K 47/26 (2006.01) , A61K 47/36 (2006.01) , A61K 9/48 (2006.01) | | Title | FORMULERINGER AF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLIN-1,3-DION | | Int. application no. | US2010035357 | | Int. publication no. | WO2010135396 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
